Clinical Trials Logo
  1. Home
  2. InVitro Fertilization
  3. NCT02383394
  4. Details
NCT02383394 Clinical Trial

Factors Associated With Pregnancy Loss in IVF Women

Invitro Fertilization Clinical Trial

Official title:
Factors Associated With Second-Trimester Pregnancy Loss in Women With Normal Uterine Anatomy Undergoing In Vitro Fertilization

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT02383394
Other study ID # 131
Secondary ID
Status Recruiting
Phase N/A
First received March 4, 2015
Last updated April 4, 2017
Start date April 2015
Est. completion date August 2017

Study information
Verified date April 2017
Source Cairo University
Contact Ahmed M Maged, MD
Phone 01005227404
Email prof.ahmedmaged@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Maternal and clinical characteristics associated with spontaneous second-trimester pregnancy loss (between 12 1/7 and 23 6/7 weeks of gestation) will be assessed.

Description:

Maternal characteristics as age , parity, body mass index, previous abortion,previous failed IVF cycles, weight gain during pregnancy, physical activity, sexual relation and frequency, adherence to treatment, residency, medical history,surgical pelvic history, fever during pregnancy.

Clinical characteristics as multiple pregnancy, site of implantation, day of transfer, serum HCG day 14.

Recruitment information / eligibility
Status Recruiting
Enrollment 500
Est. completion date August 2017
Est. primary completion date May 2017
Accepts healthy volunteers No
Gender Female
Age group 21 Years to 44 Years
Eligibility Inclusion Criteria:

- Women aged 21-44 years with ongoing in vitro fertilization pregnancy (at least one fetus with fetal heart tones at 12 weeks of gestation)

Exclusion Criteria:

- abnormal uterine cavity induced abortion for medical problem

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• follow up antenatal care
ultrasound follow up of pregnancy

Locations
Country Name City State
Egypt Ahmed Maged Cairo

Sponsors (1)
Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary second trimester abortion between 12 1/7 and 23 6/7 weeks of gestation)
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03684824 - Accuracy of Ultrasound Markers Versus Biochemical Markers in Prediction of Ovarian Response in Obese Women Undergoing IVF/ICSI Treatment N/A
Not yet recruiting NCT03683043 - Comparative Study Between ICSI Results in Transvaginal Ultrasound Guided Embryo Transfer and Transabdominal Ultrasound Guided Embryo Transfer Phase 4
Recruiting NCT02329197 - Intrauterine Injection of Human Chorionic Gonadotropin Before Embryo Transfer in Women With Previous IVF Failure Phase 4
Completed NCT02764255 - Embryoscope and Reproductive Outcome N/A
Recruiting NCT02084940 - Long Acting GnRH Antagonist in PCOS Women Undergoing IVF N/A
Completed NCT02674178 - FSH/LH Ratio as a Predictor of IVF Outcome in Young and Older Women Phase 4
Completed NCT01576991 - Telomeres and Reproduction in Women N/A
Recruiting NCT03457233 - The Impact of Body Weight on Reproductive Outcomes in Poor Ovarian Responders in ICSI Cycles N/A
Completed NCT02660125 - Endometrial Injury and Implantation Rates Before First ICSI Cycle N/A
Completed NCT03402620 - Poor Responders Infertile Patients -A Great Clinical Challenge N/A
Completed NCT03831542 - Effect of Follicular Flushing in Patients With Mono-follicular Growth Undergoing In Vitro Fertilization
Not yet recruiting NCT03263299 - Value of Cabergoline and Low Dose Aspirin in Poor Responders Undergoing ICSI-ET With GnRH Agonist Flare-Up-Protocol Phase 4
Completed NCT03118830 - Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI Phase 4